| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceleration of rare disease therapeutic development: a case study of AGIL-AADC
|
Das, Sonya
|
|
2019
|
24 |
3 |
p. 678-684
|
artikel
|
| 2 |
Adverse drug reactions on sexual functioning: a systematic overview
|
Gordijn, Rineke
|
|
2019
|
24 |
3 |
p. 890-897
|
artikel
|
| 3 |
An approach towards enhancement of a screening library: The Next Generation Library Initiative (NGLI) at Bayer — against all odds?
|
Follmann, Markus
|
|
2019
|
24 |
3 |
p. 668-672
|
artikel
|
| 4 |
Artificial intelligence in drug development: present status and future prospects
|
Mak, Kit-Kay
|
|
2019
|
24 |
3 |
p. 773-780
|
artikel
|
| 5 |
A unified mapping framework of multifaceted pharmacodynamic responses to hypertension interventions
|
Wang, Qian
|
|
2019
|
24 |
3 |
p. 883-889
|
artikel
|
| 6 |
Behavior, experience, skill, and training (BEST): a four-pillar framework for career development in science
|
Ashkenazy, Rebecca
|
|
2019
|
24 |
3 |
p. 665-667
|
artikel
|
| 7 |
Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?
|
Brown, Hannah K.
|
|
2019
|
24 |
3 |
p. 763-772
|
artikel
|
| 8 |
Computational modeling for formulation design
|
Mehta, Chetan Hasmukh
|
|
2019
|
24 |
3 |
p. 781-788
|
artikel
|
| 9 |
Contents page 3
|
|
|
2019
|
24 |
3 |
p. iii
|
artikel
|
| 10 |
Contents page 2
|
|
|
2019
|
24 |
3 |
p. ii
|
artikel
|
| 11 |
Contents page 1
|
|
|
2019
|
24 |
3 |
p. i
|
artikel
|
| 12 |
Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor
|
Chai, Sergio C.
|
|
2019
|
24 |
3 |
p. 906-915
|
artikel
|
| 13 |
Efficient drug discovery by rational lead hybridization based on crystallographic overlay
|
Zhang, Shuo
|
|
2019
|
24 |
3 |
p. 805-813
|
artikel
|
| 14 |
Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents
|
Ediriweera, Meran Keshawa
|
|
2019
|
24 |
3 |
p. 685-702
|
artikel
|
| 15 |
Fullerene-based delivery systems
|
Kazemzadeh, Houman
|
|
2019
|
24 |
3 |
p. 898-905
|
artikel
|
| 16 |
Functionalized nanographene oxide in biomedicine applications: bioinspired surface modifications, multidrug shielding, and site-specific trafficking
|
Cheng, Hao
|
|
2019
|
24 |
3 |
p. 749-762
|
artikel
|
| 17 |
Gastric-acid-mediated drug–drug interactions with direct-acting antiviral medications for hepatitis C virus infection: clinical relevance and mitigation strategies
|
Yu, Guo
|
|
2019
|
24 |
3 |
p. 845-857
|
artikel
|
| 18 |
Hurdles in gene therapy regulatory approval: a retrospective analysis of European Marketing Authorization Applications
|
Carvalho, Marta
|
|
2019
|
24 |
3 |
p. 823-828
|
artikel
|
| 19 |
Orphan drugs: major development challenges at the clinical stage
|
Fonseca, Diogo A.
|
|
2019
|
24 |
3 |
p. 867-872
|
artikel
|
| 20 |
Paving the way for successful islet encapsulation
|
Dimitrioglou, Nikos
|
|
2019
|
24 |
3 |
p. 737-748
|
artikel
|
| 21 |
Pharmaceutical cocrystals: from serendipity to design to application
|
Kavanagh, Oisin N.
|
|
2019
|
24 |
3 |
p. 796-804
|
artikel
|
| 22 |
Phosphinic acids: current status and potential for drug discovery
|
Abdou, Moaz M.
|
|
2019
|
24 |
3 |
p. 916-929
|
artikel
|
| 23 |
Post-translational modification of ESKAPE pathogens as a potential target in drug discovery
|
Tiwari, Vishvanath
|
|
2019
|
24 |
3 |
p. 814-822
|
artikel
|
| 24 |
Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products
|
Beg, Sarwar
|
|
2019
|
24 |
3 |
p. 717-725
|
artikel
|
| 25 |
Repurposing host-based therapeutics to control coronavirus and influenza virus
|
Li, Cui-Cui
|
|
2019
|
24 |
3 |
p. 726-736
|
artikel
|
| 26 |
Solid nanoparticles for oral antimicrobial drug delivery: a review
|
Raza, Aun
|
|
2019
|
24 |
3 |
p. 858-866
|
artikel
|
| 27 |
Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases
|
Tomitaka, Asahi
|
|
2019
|
24 |
3 |
p. 873-882
|
artikel
|
| 28 |
TGFβ and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension
|
Tielemans, Birger
|
|
2019
|
24 |
3 |
p. 703-716
|
artikel
|
| 29 |
The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions
|
Polamreddy, Prasanthi
|
|
2019
|
24 |
3 |
p. 789-795
|
artikel
|
| 30 |
The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development
|
Li, Jing
|
|
2019
|
24 |
3 |
p. 829-834
|
artikel
|
| 31 |
Ultrasmall iron oxide nanoparticles: synthesis, surface modification, assembly, and biomedical applications
|
Song, Cong
|
|
2019
|
24 |
3 |
p. 835-844
|
artikel
|
| 32 |
When more isn’t merrier: pharmaceutical alliance networks and breakthrough innovation
|
Dong, John Qi
|
|
2019
|
24 |
3 |
p. 673-677
|
artikel
|
Tijdschrift beschrijving